According to a study presented at the American Society of Clinical Oncology’s 2024 annual meeting, artificial intelligence may be able to reach underserved populations by re-engaging individuals who previously missed or avoided an appointment.
After researchers used an AI tool to reengage 2,400 patients who missed colonoscopies, 58% of patients who engaged with the AI accepted a live transfer to a staff member to reschedule their appointments, and 25% of patients completed their colonoscopy screening.
Additionally, giving patients more choice in their colorectal cancer screening options could increase the number of patients who get screened, according to a May study from the Perelman School of Medicine in Philadelphia.
When patients were given the choice between a take-home test kit or undergoing a colonoscopy, more patients voluntarily undergo screenings.
These two studies may show health systems effective ways to engage patients for routine screenings as colorectal cancer rates continue to rise nationwide.
